Prices are updated after-hours


Sort by: after hours percent change | delayed percent change | gain open | gain high | gain close | publishing date

symbols : Bmy    save search

Cancer Immunotherapy Market Expands with Rising Adoption of Target Therapy in Cancer Treatment, States TMR Report
Published: 2022-06-27 (Crawled : 16:00) - prnewswire.com
AZNCF | News | $129.21 | twitter stocktwits trandingview |
Health Technology
| | O: -1.55% H: 4.43% C: 0.03%
NVS | News | $85.28 0.53% 0.02% | twitter stocktwits trandingview |
Health Technology
| | O: 1.86% H: 1.05% C: 0.24%
LLY | News S | $327.27 0.51% 0.04% | twitter stocktwits trandingview |
Health Technology
| | O: 1.32% H: 0.0% C: 0.0%
GSK | News | $43.7 0.02% 0.05% | twitter stocktwits trandingview |
Health Technology
| | O: -0.16% H: 0.61% C: 0.18%
GLAXF | News | $21.1 | twitter stocktwits trandingview |
Health Technology
| | O: 0.47% H: 3.73% C: 3.73%
PFE | News | $51.88 0.56% 0.04% | twitter stocktwits trandingview |
Health Technology
| | O: 1.46% H: 1.45% C: 0.78%
SPPI | News A | $0.8667 -1.51% 0.0% | twitter stocktwits trandingview |
Health Technology
| | O: 0.0% H: 2.28% C: -2.27%
SNYNF | News | $104.5 | twitter stocktwits trandingview |
Health Technology
| | O: 4.15% H: 0.0% C: 0.0%
BMY | News | $79.98 1.29% 0.34% | twitter stocktwits trandingview |
Health Technology
| | O: 0.78% H: 1.72% C: 0.95%
SNY | News | $52.62 -1.5% -0.41% | twitter stocktwits trandingview |
Health Technology
| | O: 0.53% H: 0.0% C: 0.0%
AZN | News | $66.465 -0.65% -0.42% | twitter stocktwits trandingview |
Health Technology
| | O: -0.36% H: 1.22% C: 0.38%

immunotherapy report therapy cancer market
Valued to be $3.4 Billion by 2026, Critical Care Therapeutics Slated for Robust Growth Worldwide
Published: 2022-06-27 (Crawled : 12:20) - prnewswire.com
BMY | News | $79.98 1.29% 0.34% | twitter stocktwits trandingview |
Health Technology
| | O: 0.78% H: 1.72% C: 0.95%
BAX | News | $66.71 -0.11% 0.0% | twitter stocktwits trandingview |
Health Technology
| | O: 4.39% H: 0.97% C: -0.09%
BMRN | News | $85.03 -2.1% -0.4% | twitter stocktwits trandingview |
Health Technology
| | O: 1.23% H: 0.57% C: -1.48%
NVO | News | $112.89 0.69% 0.0% | twitter stocktwits trandingview |
Health Technology
| | O: 0.78% H: 0.97% C: 0.19%
KMDA | News | $4.61 0.0% | twitter stocktwits trandingview |
Health Technology
| | O: -1.52% H: 0.67% C: -0.88%
ABEO | News | $0.1824 7.29% 6.47% | twitter stocktwits trandingview |
Health Technology
| | O: -5.43% H: 9.2% C: 5.23%

care for therapeutics growth
Bristol Myers Squibb Presents New Data Showing Effect of Early Zeposia (ozanimod) Treatment in Improving and Preserving Cognitive Function in People With Relapsing Multiple Sclerosis
Published: 2022-06-24 (Crawled : 20:00) - biospace.com/
BMY | News | $79.98 1.29% 0.34% | twitter stocktwits trandingview |
Health Technology
| | O: 1.2% H: 0.0% C: 0.0%

treatment sclerosis
New Data Highlight Immune Response to COVID-19 Vaccines in Individuals with Relapsing Forms of Multiple Sclerosis Treated with Zeposia (ozanimod)
Published: 2022-06-24 (Crawled : 20:00) - biospace.com/
BMY | News | $79.98 1.29% 0.34% | twitter stocktwits trandingview |
Health Technology
| | O: 1.2% H: 0.0% C: 0.0%

covid-19 response sclerosis
SHAREHOLDER ALERT: Weiss Law Reminds MBII, VMW, TPTX, and HMTV Shareholders About Its Ongoing Investigations
Published: 2022-06-24 (Crawled : 19:00) - prnewswire.com
AVGO | $505.89 -0.63% 0.18% | twitter stocktwits trandingview |
Electronic Technology
| Email alert Add to watchlist
HMTV | $7.925 16.2% 0.0% | twitter stocktwits trandingview |
Consumer Services
| Email alert Add to watchlist
VMW | $117.66 -0.25% 0.68% | twitter stocktwits trandingview |
Technology Services
| Email alert Add to watchlist
BMY | News | $79.98 1.29% 0.34% | twitter stocktwits trandingview |
Health Technology
| Email alert Add to watchlist
MBII | News | $1.02 4.4% 3.38% | twitter stocktwits trandingview |
Process Industries
| Email alert Add to watchlist
TPTX | $75.27 0.13% 0.0% | twitter stocktwits trandingview |
Health Technology
| Email alert Add to watchlist

ongoing
European Medicines Agency Validates Bristol Myers Squibb’s Application for CAR T Cell Therapy Breyanzi in Relapsed or Refractory Large B-cell Lymphoma After First-Line Therapy
Published: 2022-06-20 (Crawled : 12:00) - biospace.com/
BMY | News | $79.98 1.29% 0.34% | twitter stocktwits trandingview |
Health Technology
| Email alert Add to watchlist

for application therapy
SHAREHOLDER ALERT: Weiss Law Reminds TPTX, PCSB, SREV, and HMTV Shareholders About Its Ongoing Investigations
Published: 2022-06-17 (Crawled : 19:00) - prnewswire.com
CNXC | News | $147.67 1.63% -0.04% | twitter stocktwits trandingview |
Information
| Email alert Add to watchlist
BMY | News | $79.98 1.29% 0.34% | twitter stocktwits trandingview |
Health Technology
| Email alert Add to watchlist
TPTX | $75.27 0.13% 0.0% | twitter stocktwits trandingview |
Health Technology
| Email alert Add to watchlist
BRKL | $13.44 0.9% 0.0% | twitter stocktwits trandingview |
Finance
| Email alert Add to watchlist
SREV | News | $1.45 -2.76% | twitter stocktwits trandingview |
Technology Services
| Email alert Add to watchlist
PCSB A | $19.17 0.31% 0.0% | twitter stocktwits trandingview |
Finance
| Email alert Add to watchlist
HMTV | $7.925 16.2% 0.0% | twitter stocktwits trandingview |
Consumer Services
| Email alert Add to watchlist
CNXCV | News | $2.27 0% | twitter stocktwits trandingview |
Commercial Services
| Email alert Add to watchlist

ongoing
Global High Potency Active Pharmaceutical Ingredient (HPAPI) Market Report 2022 with Competitive Landscape Analysis of Eli Lily and Co; Novartis; Bristol-Myers Squibb; Roche Diagnostics; Sanofi
Published: 2022-06-17 (Crawled : 12:20) - prnewswire.com
SNY | News | $52.62 -1.5% -0.41% | twitter stocktwits trandingview |
Health Technology
| | O: 1.39% H: 0.0% C: 0.0%
AZN | News | $66.465 -0.65% -0.42% | twitter stocktwits trandingview |
Health Technology
| | O: 0.59% H: 0.0% C: 0.0%
SNYNF | News | $104.5 | twitter stocktwits trandingview |
Health Technology
| | O: -1.76% H: 5.75% C: 5.5%
BMY | News | $79.98 1.29% 0.34% | twitter stocktwits trandingview |
Health Technology
| | O: 0.57% H: 0.0% C: 0.0%
GLAXF | News | $21.1 | twitter stocktwits trandingview |
Health Technology
| | O: 0.01% H: 0.17% C: 0.17%
NVSEF | News | $84.01 | twitter stocktwits trandingview |
Health Technology
| | O: 0.74% H: 0.52% C: -3.23%
GSK | News | $43.7 0.02% 0.05% | twitter stocktwits trandingview |
Health Technology
| | O: -0.24% H: 0.0% C: 0.0%
AZNCF | News | $129.21 | twitter stocktwits trandingview |
Health Technology
| | O: 1.89% H: 0.0% C: -0.64%
NVS | News | $85.28 0.53% 0.02% | twitter stocktwits trandingview |
Health Technology
| | O: 0.07% H: 0.0% C: 0.0%

active report roche sanofi market diagnostic
Immunomodulators Market: Trends & Opportunities | Global Industry Analysis [2021-2031] The demand in the global immunomodulators market is expected to increment at a potent CAGR during the forecast period of 2017 to 2025, which can be attributed to a number of key factors, such as increasing adoption of monoclonal antibodies, presence of strong pipeline portfolio, strong adoption of TNF-alpha inhibitors and B-cell inhibitors, advancements in the diagnostic tools, and the development of novel therapies using innovative technologies. In Vitro Diagnostics (IVD) and Laboratory Developed Tests for Autoimmune Diseases Market | Forecast [2021-2031] In vitro diagnostics and laboratory developed tests for autoimmune diseases are a key part of the global healthcare sector and are likely to account for a significant share in the same in the coming years due to the rising investment in the healthcare sector from various channels. Isothermal Nucleic Acid Amplification Technology Market Analysis and Opportunity Assessment up to 2031 Wilmington, Delaware, United States: Surge in the prevalence of different infectious diseases globally is projected to create substantial opportunities for sales growth in the isothermal nucleic acid amplification technology market during the forecast period of 2021 to 2031. Medical Sensors Market to Gain US$ 32.15 Bn by 2028, Growing Awareness about Health and Fitness to Drive Global Market Wilmington, Delaware, United States: According to the report, the global medical sensors market was valued at US$ 15.23 Bn in 2020 and is projected to expand at a CAGR of 9.9% from 2021 to 2028. Oral Care Products Market Segmentation and Analysis Report, 2031 Wilmington, Delaware, United States: The global oral care products market is anticipated to witness moderate growth during the forecast period between 2021 and 2031. Pharmacovigilance Market: Size | Share | Trends | Global Industry Outlook, 2031 Pharmacovigilance is a process refereeing to the detection, collection, prevention, and monitoring of negative effects that may occur because of the use of pharmaceutical products and other drugs. Stoma Care Market Insights by Size, Status and Forecast 2031 Wilmington, Delaware, United States: Because of the high frequency of bladder cancer and colorectal cancer, growing number of activities to develop awareness about stoma, rising demand for stoma care and accessories, and technological developments is expected to drive global stoma care market in the near future. Structural Biology and Molecular Modeling Techniques Market | Global Industry Analysis [2021-2031] The global structural biology and molecular modeling techniques market is a novel conception in the global healthcare sector and has already made key contributions in obtaining remedies to a number of diseases. Addiction Treatment Market to Generate US$ 12 Bn by 2030 | Growth & Key Business Strategies Wilmington, Delaware, United States: According to the report, the global addiction treatment market was valued at ~US$ 6 Bn in 2019 and is projected to expand at a CAGR of ~6% from 2020 to 2030. Antibacterial Drugs Market: Increasing Prevalence of Infectious Diseases to Drive the Market Wilmington, Delaware, United States: Bacterial drugs are the substances that may destroy or constrain the microorganism growth such as bacteria. Antifungal Drugs Market Demand and Global Competitive Insights 2031 Wilmington, Delaware, United States: The growing threat of fungal infections among a considerable chunk of the global populace is estimated to bring considerable growth prospects for the antifungal drugs market during the forecast period of 2021-2031. Bioimpendance Analysers Market Segmentation and Analysis Report, 2031 Wilmington, Delaware, United States: The demand in the global bioimpendance analysers market is surging owing to high growth potential amongst emerging economies such as Brazil and India. Bioinformatics Services Market Worldwide Major Trend Outlook 2021 to 2031 Wilmington, Delaware, United States: The essential types of services provided by the vendors and players functional within the global bioinformatics services market include data analysis, gene expression, sequencing, database management, and discovery, among others. Biomedical Refrigerators and Freezers Market: Trends, Regional Outlook and Competitive Analysis [2021-2031]
Published: 2022-06-17 (Crawled : 08:00) - biospace.com/
NVS | News | $85.28 0.53% 0.02% | twitter stocktwits trandingview |
Health Technology
| | O: 0.07% H: 0.0% C: 0.0%
LLY | News S | $327.27 0.51% 0.04% | twitter stocktwits trandingview |
Health Technology
| | O: 0.33% H: 0.0% C: 0.0%
NVSEF | News | $84.01 | twitter stocktwits trandingview |
Health Technology
| | O: 0.74% H: 0.52% C: -3.23%
JNJ | News | $182.12 -0.09% 0.1% | twitter stocktwits trandingview |
Health Technology
| | O: 1.35% H: 0.0% C: 0.0%
BMY | News | $79.98 1.29% 0.34% | twitter stocktwits trandingview |
Health Technology
| | O: 0.57% H: 0.0% C: 0.0%

sales treatment care trends brazil services for antibacterial growing diagnostic health expected infections technology diagnostics potential molecular cancer growth negative market
Bristol Myers Squibb Elects Deepak L. Bhatt, M.D., M.P.H. to Board of Directors
Published: 2022-06-15 (Crawled : 22:00) - biospace.com/
BMY | News | $79.98 1.29% 0.34% | twitter stocktwits trandingview |
Health Technology
| | O: 0.4% H: 0.6% C: -0.19%


Global Axial Spondyloarthritis Market Research Repoirt 2022: Biopharmaceutical Companies are Trying to Match Themselves with New Technologies in the Market to Improve the Overall System
Published: 2022-06-14 (Crawled : 11:00) - prnewswire.com
ABBV | News | $153.14 0.53% 0.04% | twitter stocktwits trandingview |
Health Technology
| | O: -1.04% H: 0.87% C: -1.31%
JNJ | News | $182.12 -0.09% 0.1% | twitter stocktwits trandingview |
Health Technology
| | O: 0.43% H: 0.0% C: 0.0%
BMY | News | $79.98 1.29% 0.34% | twitter stocktwits trandingview |
Health Technology
| | O: -0.4% H: 0.33% C: -0.91%
UCBJY | $42.91 | twitter stocktwits trandingview |
Manufacturing
| | O: -0.22% H: 0.0% C: -1.02%
PFE | News | $51.88 0.56% 0.04% | twitter stocktwits trandingview |
Health Technology
| | O: -2.24% H: 0.0% C: 0.0%
AMGN | News | $244.89 -0.2% -0.56% | twitter stocktwits trandingview |
Health Technology
| | O: -0.41% H: 0.73% C: -0.54%
TAK | News | $14.06 1.59% 0.0% | twitter stocktwits trandingview |
Health Technology
| | O: -0.04% H: 0.0% C: 0.0%
LLY | News S | $327.27 0.51% 0.04% | twitter stocktwits trandingview |
Health Technology
| | O: -0.49% H: 0.98% C: 0.56%

research system companies market
SHAREHOLDER ALERT: Weiss Law Reminds TPTX, PCSB, SREV, and HMTV Shareholders About Its Ongoing Investigations
Published: 2022-06-10 (Crawled : 19:00) - prnewswire.com
SREV | News | $1.45 -2.76% | twitter stocktwits trandingview |
Technology Services
| Email alert Add to watchlist
CNXCV | News | $2.27 0% | twitter stocktwits trandingview |
Commercial Services
| Email alert Add to watchlist
BRKL | $13.44 0.9% 0.0% | twitter stocktwits trandingview |
Finance
| Email alert Add to watchlist
PCSB A | $19.17 0.31% 0.0% | twitter stocktwits trandingview |
Finance
| Email alert Add to watchlist
BMY | News | $79.98 1.29% 0.34% | twitter stocktwits trandingview |
Health Technology
| Email alert Add to watchlist
HMTV | $7.925 16.2% 0.0% | twitter stocktwits trandingview |
Consumer Services
| Email alert Add to watchlist
TPTX | $75.27 0.13% 0.0% | twitter stocktwits trandingview |
Health Technology
| Email alert Add to watchlist
CNXC | News | $147.67 1.63% -0.04% | twitter stocktwits trandingview |
Information
| Email alert Add to watchlist

ongoing
Bristol Myers Squibb to Report Results for Second Quarter 2022 on July 27, 2022
Published: 2022-06-08 (Crawled : 12:00) - biospace.com/
BMY | News | $79.98 1.29% 0.34% | twitter stocktwits trandingview |
Health Technology
| | O: 1.41% H: 0.39% C: -0.44%

report for results
Bristol Myers Squibb to Participate in Goldman Sachs 43rd Annual Global Healthcare Conference
Published: 2022-06-07 (Crawled : 12:00) - biospace.com/
BMY | News | $79.98 1.29% 0.34% | twitter stocktwits trandingview |
Health Technology
| | O: 0.36% H: 0.0% C: 0.0%

conference
Ayala Pharmaceuticals Announces Data on AL101 in Adenoid Cystic Carcinoma (ACC) at 2022 ASCO Annual Meeting
Published: 2022-06-06 (Crawled : 16:00) - biospace.com/
AYLA | $1.13 5.61% 18.22% | twitter stocktwits trandingview |
Health Technology
| | O: 0.0% H: 3.42% C: 2.33%
BMY | News | $79.98 1.29% 0.34% | twitter stocktwits trandingview |
Health Technology
| | O: 1.03% H: 0.0% C: 0.0%

al101 asco
Three-Year Data from Phase 3 CheckMate -9LA Trial Demonstrate Long-Term, Durable Survival Outcomes of Opdivo (nivolumab) Plus Yervoy (ipilimumab)
Published: 2022-06-06 (Crawled : 12:00) - biospace.com/
BMY | News | $79.98 1.29% 0.34% | twitter stocktwits trandingview |
Health Technology
| | O: 1.03% H: 0.0% C: 0.0%

opdivo trial plus
Landmark Five-Year Data from Phase 3 CheckMate -227 Trial Demonstrate Long-Term, Durable Survival Outcomes with Opdivo (nivolumab) Plus Yervoy (ipilimumab) in First-Line Treatment of Patients with Metastatic Non-Small Cell Lung Cancer
Published: 2022-06-06 (Crawled : 12:00) - biospace.com/
BMY | News | $79.98 1.29% 0.34% | twitter stocktwits trandingview |
Health Technology
| | O: 1.03% H: 0.0% C: 0.0%

treatment opdivo trial plus cancer
SHAREHOLDER ALERT: Weiss Law Investigates Turning Point Therapeutics, Inc.
Published: 2022-06-03 (Crawled : 19:00) - prnewswire.com
BMY | News | $79.98 1.29% 0.34% | twitter stocktwits trandingview |
Health Technology
| Email alert Add to watchlist
TPTX | $75.27 0.13% 0.0% | twitter stocktwits trandingview |
Health Technology
| Email alert Add to watchlist


Bristol Myers Squibb to Acquire Turning Point Therapeutics, a Leading Precision Oncology Company
Published: 2022-06-03 (Crawled : 12:00) - biospace.com/
BMY | News | $79.98 1.29% 0.34% | twitter stocktwits trandingview |
Health Technology
| | O: -1.4% H: 0.0% C: 0.0%
TPTX | $75.27 0.13% 0.0% | twitter stocktwits trandingview |
Health Technology
| | O: 120.04% H: 0.0% C: 0.0%


Idiopathic Pulmonary Fibrosis Market Size to hit USD 5326.8 Million in 2028 | Growing at 7.1 % CAGR, Says Brandessence Market Research
Published: 2022-06-03 (Crawled : 12:00) - prnewswire.com
BIIB | $213.56 0.77% 0.0% | twitter stocktwits trandingview |
Health Technology
| | O: 1.16% H: 3.3% C: 1.27%
GLPG | $55.94 0.32% 2.13% | twitter stocktwits trandingview |
Health Technology
| | O: 0.29% H: 2.68% C: 2.39%
AZNCF | News | $129.21 | twitter stocktwits trandingview |
Health Technology
| | O: -0.4% H: 4.05% C: -1.35%
FGEN F | $11.66 0.34% 0.0% | twitter stocktwits trandingview |
Health Technology
| | O: 1.57% H: 2.99% C: 2.99%
AZN | News | $66.465 -0.65% -0.42% | twitter stocktwits trandingview |
Health Technology
| | O: -0.56% H: 0.82% C: -0.64%
BMY | News | $79.98 1.29% 0.34% | twitter stocktwits trandingview |
Health Technology
| | O: -1.4% H: 0.0% C: 0.0%

fibrosis research growing market
Your saved searches
Save your searches and get alerts when important news are released.

Mentioned Today
ABBV | News | $153.14 0.53% 0.04% | twitter stocktwits trandingview |
Health Technology

APPN | News 4 | $54.46 -1.05% 0.38% | twitter stocktwits trandingview |
Technology Services

APPS | News | $17.62 1.62% 5.48% | twitter stocktwits trandingview |
Technology Services

APYX | News | $6.04 1.51% 0.0% | twitter stocktwits trandingview |
Health Technology

BNPQF | News | $50.78 | twitter stocktwits trandingview |
Finance

BNPQY | News | $25.46 | twitter stocktwits trandingview |
Finance and Insurance

BNPZY | News | $ 0% | twitter stocktwits trandingview |
Finance and Insurance

CNXC | News | $147.67 1.63% -0.04% | twitter stocktwits trandingview |
Information

CNXCV | News | $2.27 0% | twitter stocktwits trandingview |
Commercial Services

DMYD | News | $16.21 0% | twitter stocktwits trandingview |
Finance

DMYT | News | $22.76 0% | twitter stocktwits trandingview |
Finance

DRE | News | $56.17 -2.23% 0.0% | twitter stocktwits trandingview |
Finance

EPZM | News | $1.47 54.09% 7.97% | twitter stocktwits trandingview |
Health Technology

ET | News | $10.14 0.4% 0.59% | twitter stocktwits trandingview |
Industrial Services

FBNC | News | $35.7 2.32% 0.0% | twitter stocktwits trandingview |
Finance

FBP | News | $13.52 0.67% 0.0% | twitter stocktwits trandingview |
Finance

FTRP | News | $0.81 1.25% 0.0% | twitter stocktwits trandingview |
Health Care and Social Assistan...

GRRB | News | $30.6 | twitter stocktwits trandingview |
Finance and Insurance

HR | News | $27.23 1.38% 0.0% | twitter stocktwits trandingview |
Finance

HTA | News | $27.7 -0.22% 0.0% | twitter stocktwits trandingview |
Finance

IE | News 0 d new | $ 0% | twitter stocktwits trandingview |
n/a

IONQ | News | $4.83 -5.48% 2.07% | twitter stocktwits trandingview |
Professional, Scientific, and T...

LLY | News 4 | $327.27 0.51% 0.04% | twitter stocktwits trandingview |
Health Technology

LMPX | News | $4.62 0.43% 0.0% | twitter stocktwits trandingview |
Technology Services

NFLX | News | $189.14 -0.9% 0.52% | twitter stocktwits trandingview |
Consumer Services

OBCI | News | $12.86 0.0% | twitter stocktwits trandingview |
Consumer Non-Durables

OMC | News | $64.75 0.23% 0.0% | twitter stocktwits trandingview |
Commercial Services

ONEW | News | $35.25 3.68% 0.0% | twitter stocktwits trandingview |
Retail Trade

OSCR | News | $4.55 2.94% 0.0% | twitter stocktwits trandingview |

PACB | News | $5.3 -5.53% -1.78% | twitter stocktwits trandingview |
Health Technology

PEGA | News | $51.68 -1.97% 0.0% | twitter stocktwits trandingview |
Technology Services

PFHC | News | $19.75 6.35% -4.95% | twitter stocktwits trandingview |

PLD | News | $120.21 -1.94% 0.54% | twitter stocktwits trandingview |
Finance

PSORF | News | $9.55 0% | twitter stocktwits trandingview |
Consumer Services

RDUS | News | $10.205 0.94% -0.4% | twitter stocktwits trandingview |
Health Technology

SNY | News | $52.62 -1.5% -0.41% | twitter stocktwits trandingview |
Health Technology

SNYNF | News | $104.5 | twitter stocktwits trandingview |
Health Technology

SPRO | News | $0.931 -0.96% 3.19% | twitter stocktwits trandingview |
Health Technology

SREV | News | $1.45 -2.76% | twitter stocktwits trandingview |
Technology Services

TGTX | News | $4.34 -1.36% -2.05% | twitter stocktwits trandingview |
Health Technology

TUP | News 4 | $7.16 1.42% 0.0% | twitter stocktwits trandingview |
Producer Manufacturing

USAK | News | $30.85 -0.48% -0.39% | twitter stocktwits trandingview |
Transportation

USWS | News | $0.995 4.08% -0.63% | twitter stocktwits trandingview |
Finance

VRCA | News | $2.195 4.03% 10.43% | twitter stocktwits trandingview |
Health Technology

WWE | News | $61.0 0.63% 0.0% | twitter stocktwits trandingview |
Consumer Services

XRAY | News | $36.74 -0.05% 0.0% | twitter stocktwits trandingview |
Health Technology

ZEN | News | $74.65 0.65% -0.07% | twitter stocktwits trandingview |
Technology Services